These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18950568)

  • 21. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Lecordier L; Vanhollebeke B; Poelvoorde P; Tebabi P; Paturiaux-Hanocq F; Andris F; Lins L; Pays E
    PLoS Pathog; 2009 Dec; 5(12):e1000685. PubMed ID: 19997494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis.
    Bisser S; Ouwe-Missi-Oukem-Boyer ON; Toure FS; Taoufiq Z; Bouteille B; Buguet A; Mazier D
    Int J Parasitol; 2006 May; 36(5):529-40. PubMed ID: 16600243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness.
    Vanhamme L; Pays E
    Int J Parasitol; 2004 Jul; 34(8):887-98. PubMed ID: 15217727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are fitness costs associated with resistance to human serum in Trypanosoma brucei rhodesiense?
    Coleman PG; Welburn SC
    Trends Parasitol; 2004 Jul; 20(7):311-5. PubMed ID: 15193561
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection.
    Gillett MP; Owen JS
    J Lipid Res; 1992 Apr; 33(4):513-23. PubMed ID: 1527475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental sensing by African trypanosomes.
    Roditi I; Schumann G; Naguleswaran A
    Curr Opin Microbiol; 2016 Aug; 32():26-30. PubMed ID: 27131101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans.
    Vanhollebeke B; De Muylder G; Nielsen MJ; Pays A; Tebabi P; Dieu M; Raes M; Moestrup SK; Pays E
    Science; 2008 May; 320(5876):677-81. PubMed ID: 18451305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleeping sickness: a tale of two diseases.
    Welburn SC; Fèvre EM; Coleman PG; Odiit M; Maudlin I
    Trends Parasitol; 2001 Jan; 17(1):19-24. PubMed ID: 11137736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier.
    Nikolskaia OV; Kim YV; Kovbasnjuk O; Kim KJ; Grab DJ
    Int J Parasitol; 2006 May; 36(5):513-9. PubMed ID: 16620822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera.
    Poelvoorde P; Vanhamme L; Van Den Abbeele J; Switzer WM; Pays E
    Mol Biochem Parasitol; 2004 Mar; 134(1):155-7. PubMed ID: 14747153
    [No Abstract]   [Full Text] [Related]  

  • 32. [Human resistance to African trypanosoma infections].
    Perez-Morga D
    Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human serum resistant Trypanosoma brucei rhodesiense accumulates similar amounts of fluorescently-labelled trypanolytic human HDL3 particles as human serum sensitive T.b. brucei.
    Lorenz P; Owen JS; Hassall DG
    Mol Biochem Parasitol; 1995 Oct; 74(1):113-8. PubMed ID: 8719251
    [No Abstract]   [Full Text] [Related]  

  • 34. The significance of human serum sensitivity in the context of T.B. rhodesiense sleeping sickness epidemiology and control.
    Rickman LR
    East Afr Med J; 1992 May; 69(5):272-8. PubMed ID: 1644047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
    Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
    Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of the primate trypanolytic factor APOL1.
    Thomson R; Genovese G; Canon C; Kovacsics D; Higgins MK; Carrington M; Winkler CA; Kopp J; Rotimi C; Adeyemo A; Doumatey A; Ayodo G; Alper SL; Pollak MR; Friedman DJ; Raper J
    Proc Natl Acad Sci U S A; 2014 May; 111(20):E2130-9. PubMed ID: 24808134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution and spread of human African trypanosomiasis: value of genetic identification of the trypanosomes].
    Truc P; Cuny G
    Med Trop (Mars); 2001; 61(4-5):433-6. PubMed ID: 11803837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding.
    DeJesus E; Kieft R; Albright B; Stephens NA; Hajduk SL
    PLoS Pathog; 2013; 9(4):e1003317. PubMed ID: 23637606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lysis of Trypanosoma brucei brucei by human serum.
    Tomlinson S; Raper J
    Nat Biotechnol; 1996 Jun; 14(6):717-21. PubMed ID: 9630977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.